Terms: = Breast cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2
123 results:
1. Predisposing deleterious variants in the cancer-associated human kinases in the global populations.
Khan SA; Anwar M; Gohar A; Roosan MR; Hoessli DC; Khatoon A; Shakeel M
PLoS One; 2024; 19(4):e0298747. PubMed ID: 38635549
[TBL] [Abstract] [Full Text] [Related]
2. Aspongopus chinensis ach-miR-276a-3p induces breast cancer cell cycle arrest by targeting APPL2 to regulate the CDK2-Rb-E2F1 signaling pathway.
Cai R; Khan S; Chen X; Li H; Tan J; Tian Y; Zhao S; Yin Z; Liu T; Jin D; Guo J
Toxicol Appl Pharmacol; 2024 Mar; 484():116877. PubMed ID: 38431228
[TBL] [Abstract] [Full Text] [Related]
3. Acetylcholinesterase enzyme among cancer patients a potential diagnostic and prognostic indicator a multicenter case-control study.
Ahmed GY; Osman AA; Mukhtar A
Sci Rep; 2024 Mar; 14(1):5127. PubMed ID: 38429330
[TBL] [Abstract] [Full Text] [Related]
4. In Utero Exposure to Maternal COVID-19 Vaccination and Offspring Neurodevelopment at 12 and 18 Months.
Jaswa EG; Cedars MI; Lindquist KJ; Bishop SL; Kim YS; Kaing A; Prahl M; Gaw SL; Corley J; Hoskin E; Cho YJ; Rogers E; Huddleston HG
JAMA Pediatr; 2024 Mar; 178(3):258-265. PubMed ID: 38252445
[TBL] [Abstract] [Full Text] [Related]
5. Family history of malignant or benign thyroid tumors: implications for surgical procedure management and disease-free survival.
Jiang YJ; Han ZJ; Hu YX; Zhang N; Huang T
Front Endocrinol (Lausanne); 2023; 14():1282088. PubMed ID: 38093963
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer.
Saridogan T; Akcakanat A; Zhao M; Evans KW; Yuca E; Scott S; Kirby BP; Zheng X; Ha MJ; Chen H; Ng PKS; DiPeri TP; Mills GB; Rodon Ahnert J; Damodaran S; Meric-Bernstam F
Sci Rep; 2023 Nov; 13(1):20223. PubMed ID: 37980453
[TBL] [Abstract] [Full Text] [Related]
7. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
8. Chronic stress induces pulmonary epithelial cells to produce acetylcholine that remodels lung pre-metastatic niche of breast cancer by enhancing NETosis.
Pan J; Zhang L; Wang X; Li L; Yang C; Wang Z; Su K; Hu X; Zhang Y; Ren G; Jiang J; Li P; Huang J
J Exp Clin Cancer Res; 2023 Sep; 42(1):255. PubMed ID: 37773152
[TBL] [Abstract] [Full Text] [Related]
9. The role of next-generation sequencing in the examination of signaling genes in Brca1/2-negative breast cancer cases.
Cine N; Ugurtas C; Gokbayrak M; Aydin D; Demir G; Kuru S; Sunnetci-Akkoyunlu D; Eren-Keskin S; Simsek T; Cabuk D; Aksu MG; Canturk NZ; Savli H
Ann Hum Genet; 2023 Mar; 87(1-2):28-49. PubMed ID: 36479692
[TBL] [Abstract] [Full Text] [Related]
10. The prognostic and predictive values of differential expression of exosomal receptor tyrosine kinases and associated with the PI3K/AKT/mTOR signaling in breast cancer patients undergoing neoadjuvant chemotherapy.
Guney Eskiler G; Kazan N; Haciefendi A; Deveci Ozkan A; Ozdemir K; Ozen M; Kocer HB; Yilmaz F; Kaleli S; Sahin E; Bilir C
Clin Transl Oncol; 2023 Feb; 25(2):460-472. PubMed ID: 36181664
[TBL] [Abstract] [Full Text] [Related]
11. Multi-Gene Mutation Profiling by Targeted Next-Generation Sequencing in Premenopausal breast cancer.
Zografos E; Andrikopoulou A; Papatheodoridi AM; Kaparelou M; Bletsa G; Liontos M; Dimopoulos MA; Zagouri F
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011273
[TBL] [Abstract] [Full Text] [Related]
12. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
Stubbins RJ; Korotev S; Godley LA
Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
[TBL] [Abstract] [Full Text] [Related]
13. Hormone receptor binding, selectivity and cytotoxicity of steroid D-homo lactone loaded chitosan nanoparticles for the treatment of breast and prostate cancer cells.
Kuzminac IZ; Ćelić AS; Bekić SS; Kojić V; Savić MP; Ignjatović NL
Colloids Surf B Biointerfaces; 2022 Aug; 216():112597. PubMed ID: 35636320
[TBL] [Abstract] [Full Text] [Related]
14. Molecular Biology of Bladder cancer: Potential Implications for Therapy.
McConkey DJ
Hematol Oncol Clin North Am; 2021 Jun; 35(3):457-468. PubMed ID: 33958145
[TBL] [Abstract] [Full Text] [Related]
15. Chlorpyrifos induces cell proliferation in MCF-7 and MDA-MB-231 cells, through cholinergic and Wnt/β-catenin signaling disruption, achE-R upregulation and oxidative stress generation after single and repeated treatment.
Moyano P; García JM; García J; Pelayo A; Muñoz-Calero P; Frejo MT; Anadon MJ; Naval MV; Flores A; Mirat VA; Del Pino J
Food Chem Toxicol; 2021 Jun; 152():112241. PubMed ID: 33930485
[TBL] [Abstract] [Full Text] [Related]
16. Detection of activating mutations in liquid biopsy of Egyptian breast cancer patients using targeted next-generation sequencing: a pilot study.
Kassem N; Kassem H; Kassem L; Hassan M
J Egypt Natl Canc Inst; 2021 Apr; 33(1):10. PubMed ID: 33864517
[TBL] [Abstract] [Full Text] [Related]
17. Menstrual, reproductive and hormonal factors and thyroid cancer: a hospital-based case-control study in China.
Wang M; Gong WW; He QF; Hu RY; Yu M
BMC Womens Health; 2021 Jan; 21(1):13. PubMed ID: 33407401
[TBL] [Abstract] [Full Text] [Related]
18. Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation.
Selenica P; Conlon N; Gonzalez C; Frosina D; Jungbluth AA; Beets-Tan RGH; Rao MK; Zhang Y; Benayed R; Ladanyi M; Solit DB; Chiang S; Hyman DM; Hensley ML; Soslow RA; Weigelt B; Murali R
Am J Surg Pathol; 2021 Jan; 45(1):77-92. PubMed ID: 32889887
[TBL] [Abstract] [Full Text] [Related]
19. Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients.
Erber R; Rübner M; Davenport S; Hauke S; Beckmann MW; Hartmann A; Häberle L; Gass P; Press MF; Fasching PA
Breast Cancer Res Treat; 2020 Nov; 184(2):311-324. PubMed ID: 32852708
[TBL] [Abstract] [Full Text] [Related]
20. Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers.
Antony J; Zanini E; Birtley JR; Gabra H; Recchi C
Cancer Gene Ther; 2021 Feb; 28(1-2):18-26. PubMed ID: 32595215
[TBL] [Abstract] [Full Text] [Related]
[Next]
